NOTE 8 – SUBSEQUENT EVENTS

On April 28, 2026, the Company entered into additional warrant exercise inducement agreements with certain holders of warrants originally issued in connection with the Company’s February 2026 public offering. Pursuant to these agreements, holders exercised existing warrants to purchase an aggregate of 5,715,085 shares of common stock at an exercise price of $0.70 per share, resulting in aggregate gross proceeds of approximately $4.0 million. In connection with the exercises, the Company issued unregistered Series A-5 warrants to purchase up to 4,742,860 shares of common stock and unregistered Series A-6 warrants to purchase up to 6,687,310 shares of common stock, each with an exercise price of $0.975 per share. The Company received net proceeds of approximately $3.6 million after placement agent fees and offering-related expenses.

On May 7, 2026, the Company entered into an agreement for Chief Financial Officer support services. In connection with this arrangement, Roman Franklin was appointed to serve as the Company’s Principal Financial Officer. The Company previously disclosed the appointment in its Current Report on Form 8-K filed with the Securities and Exchange Commission on May 12, 2026.

On May 21, 2026, the Company received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of this Quarterly Report. The notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq. As of the filing date of this Quarterly Report, the Company believes it has regained compliance with the Listing Rule.

Between June 1st, 2026 and the filing date, holders of the Company’s outstanding warrants exercised Series A-1 and A-2 warrants to acquire 5,613,586 shares of the Company’s common stock. Of these exercises, approximately 274,726 warrants were exercised for cash, resulting in aggregate proceeds to the Company of approximately $296,704. In addition, 6,550,778 warrants were exercised pursuant to the cashless exercise provisions of the applicable warrant agreements, resulting in the issuance of approximately 5,338,860 shares of common stock. No cash proceeds were received from the cashless exercises.

Management evaluated subsequent events through June 11, 2026, the date these condensed consolidated financial statements were issued.